Manufacturer profile
Bionpharma Inc.
Pharmaceutical company2 products tracked
2
products tracked
22,160
total reports
8
recalls on record
58.6%
serious overall
Products
showing 2 of 2
| Product | Approved | Reports ↓ | Top signal | Recalls |
|---|---|---|---|---|
| — | 12,337 | Dermatitis atopic | 8 | |
| — | 9,823 | Macular degeneration | 0 |
Recall history · 2 on record
| Date | Class | Reason | Firm |
|---|---|---|---|
| Sep 17, 2024 | I | Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria. | Bionpharma Inc. |
| Jul 16, 2019 | II | Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed. | Bionpharma Inc. |
Class I = reasonable probability of serious harm · Class II = temporary or reversible · Class III = unlikely to cause harm.
Registration status
Some products from Bionpharma Inc. are not FDA-registered for human use. For unregistered substances (peptides, SARMs without human registration), no legitimate human-use supplier exists. The absence of a sourcing route is the safety information.